A new iScience review argues that ferroptosis, an iron-driven form of cell death, links tumor and immune signals to muscle ...
Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia, or involuntary weight loss, is a major concern for many individuals with ...
Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The experimental ...
Assessment of Malnutrition and Cachexia. Secondary data extracted from electronic medical records of participants with a ...
A majority of people with advanced cancers endure cachexia, a muscle-, fat-, and organ-wasting condition that is currently incurable and can be life-threatening. Detecting and intervening early can ...
Effect of distress on total toxicity burden and activities of daily living among 382 advanced stage cancer patients: A URCC CCOP research base study. This is an ASCO Meeting Abstract from the 2014 ...
Pfizer said its experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial. Patients with the ...
A retrospective study of nearly 300 kidney cancer patients links bone metastases to dramatically accelerated skeletal muscle ...
Cancer cachexia can be deadly, and due to AEs or the tumor itself, scientists are now looking at molecular subtypes to inform treatment decisions. Cancer cachexia is a condition where the patient ...
Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results